Menu
 
Research menu
Jump to menu

Publications:  Dr Helen Storr

Rubinstein G, Osswald A, Hoster E, Losa M, Elenkova A, Zacharieva S, Machado MC, Hanzu FA et al.(2019). Time to diagnosis in Cushing's syndrome: A meta-analysis based on 5367 patients. Journal of Clinical Endocrinology and Metabolism
10.1210/clinem/dgz136
https://qmro.qmul.ac.uk/xmlui/handle/123456789/62365
Tufton N, Shapiro L, Sahdev A, Kumar AV, Martin L, Drake WM, Akker SA, Storr HL(2019). An analysis of surveillance screening for SDHB-related disease in childhood and adolescence. Endocrine Connections vol. 8, (3) 162-172.
10.1530/EC-18-0522
https://qmro.qmul.ac.uk/xmlui/handle/123456789/55593
Storr HL, Chatterjee S, Metherell LA, Foley C, Rosenfeld RG, Backeljauw PF, Dauber A, Savage MO et al.(2019). Nonclassical GH insensitivity: Characterization of mild abnormalities of GH action. Endocrine Reviews vol. 40, (2) 476-505.
10.1210/er.2018-00146
https://qmro.qmul.ac.uk/xmlui/handle/123456789/45844
Chatterjee S, Shapiro L, Rose SJ, Mushtaq T, Clayton PE, Ten SB, Bhangoo A, Kumbattae U et al.(2018). Phenotypic spectrum and responses to recombinant human IGF1 (rhIGF1) therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation. European Journal of Endocrinology vol. 178, (5) 481-489.
10.1530/EJE-18-0042
https://qmro.qmul.ac.uk/xmlui/handle/123456789/36453
Prete FP, Abdel-Aziz T, Morkane C, Brain C, Kurzawinski TR, Hindmarsh P, Dattani M, Spoudeas H et al.(2018). Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2. British Journal of Surgery vol. 105, (10) 1319-1327.
10.1002/bjs.10856
https://qmro.qmul.ac.uk/xmlui/handle/123456789/53286
Marques P, Barry S, Ronaldson A, Ogilvie A, Storr HL, Goadsby PJ, Powell M, Dang MN et al.(2018). Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members' View in an AIP Mutation-Positive Family. Int J Endocrinol vol. 2018, 8581626-8581626.
10.1155/2018/8581626
https://qmro.qmul.ac.uk/xmlui/handle/123456789/50124
Ruiz-Babot G, Balyura M, Hadjidemetriou I, Ajodha SJ, Taylor DR, Ghataore L, Taylor NF, Schubert U et al.(2018). Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells. Cell Reports vol. 22, (5) 1236-1249.
10.1016/j.celrep.2018.01.003
https://qmro.qmul.ac.uk/xmlui/handle/123456789/32031
Savage MO, Chatterjee S, Hwa V, Storr HL(2018). Growth hormone insensitivity. Encyclopedia of Endocrine Diseases,
Shapiro L, Chatterjee S, Ramadan DG, Davies KM, Savage MO, Metherell LA, Storr HL(2017). Whole-exome sequencing gives additional benefits compared to candidate gene sequencing in the molecular diagnosis of children with growth hormone or IGF-1 insensitivity. European journal of endocrinology vol. 177, (6) 485-501.
10.1530/EJE-17-0453
https://qmro.qmul.ac.uk/xmlui/handle/123456789/26028
Yordanova G, Martin L, Afshar F, Sabin I, Alusi G, Plowman NP, Riddoch F, Evanson J et al.(2016). Long-term outcomes of children treated for Cushing's disease: a single center experience. Pituitary vol. 19, (6) 612-624.
10.1007/s11102-016-0756-8
https://qmro.qmul.ac.uk/xmlui/handle/123456789/22243
Katugampola H, King PJ, Chatterjee S, Meso M, Duncan AJ, Achermann JC, Guasti L, Ghataore L et al.(2017). Kisspeptin is a novel regulator of human fetal adrenocortical development and function – a finding with important implications for the human feto-placental unit. The Journal of Clinical Endocrinology & Metabolism
10.1210/jc.2017-00763
https://qmro.qmul.ac.uk/xmlui/handle/123456789/25680
Wacharasindhu S, Panamonta O, Shapiro L, Metherell LA, Savage MO, Storr HL(2017). Young Thai sisters with growth hormone insensitivity or Laron syndrome. Asian Biomedicine vol. 11, (2) 167-170.
10.5372/1905-7415.1102.549
https://qmro.qmul.ac.uk/xmlui/handle/123456789/40303
METHERELL LA, Prasad R, Storr HL, Guasti L, Maharaj A, Meimaridou E, Hadjidemetriou I(2017). Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome. Journal of Clinical Investigation
10.1172/JCI90171
https://qmro.qmul.ac.uk/xmlui/handle/123456789/22389
Tufton N, Shapiro L, Srirangalingam U, Richards P, Sahdev A, Kumar AV, McAndrew L, Martin L et al.(2017). Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers. Clinical Endocrinology vol. 86, (2) 286-296.
10.1111/cen.13246
https://qmro.qmul.ac.uk/xmlui/handle/123456789/25948
METHERELL LA (2016). Mutations in SGPL1, encoding sphingosine-1-phosphate lyase, cause a novel form of primary adrenal insufficiency with steroid resistant nephrotic syndrome. Conference: Society for Endocrinology BES 2016 (Brighton)
10.1530/endoabs.44.OC1.1
https://qmro.qmul.ac.uk/xmlui/handle/123456789/50903
Shapiro L, Elahi S, Riddoch F, Perry LA, Martin L, Akker SA, Monson JP, Drake WM et al.(2016). Investigation for Paediatric Cushing's Syndrome Using Twenty-Four-Hour Urinary Free Cortisol Determination. Horm Res Paediatr vol. 86, (1) 21-26.
10.1159/000446913
https://qmro.qmul.ac.uk/xmlui/handle/123456789/24572
HOWARD SR, Guasti L, Ruiz-Babot G, Mancini A, David A, Storr H, Metherell LA, Sternberg MJE et al.(2016). IGSF10 mutations dysregulate gonadotropin‐releasing hormone neuronal migration resulting in delayed puberty. EMBO Molecular Medicine vol. 8, (6) 626-42.
10.15252/emmm.201606250
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18622
Howard S, Guasti L, Ruiz-Babot G, Mancini A, David A, Storr H, Metherell L, Sternberg M et al. (2016). Role of IGSF10 mutations in self-limited delayed puberty. LANCET. vol. 387, 14-14.
Yordanova G, Iotova V, Zheleva E, Bachvarov C, Bocheva Y, Galcheva S, Enchev Y, Ivanov K et al. (2016). Paediatric Cushing Disease: One Patient's Path to Cure. HORMONE RESEARCH IN PAEDIATRICS. vol. 86, 430-430.
Le Quesne Stabej P, Williams HJ, James C, Tekman M, Stanescu HC, Kleta R, Ocaka L, Lescai F et al.(2016). STAG3 truncating variant as the cause of primary ovarian insufficiency. European Journal of Human Genetics vol. 24, (1) 135-138.
10.1038/ejhg.2015.107
https://qmro.qmul.ac.uk/xmlui/handle/123456789/22342
Shapiro L, Savage M, Davies K, Metherell L, Storr H (2016). Whole Exome Sequencing can Identify Defects not Detected by Candidate Gene Sequencing in Patients with Short Stature and Features of Growth Hormone Insensitivity (GHI). HORMONE RESEARCH IN PAEDIATRICS. vol. 86, 47-47.
https://qmro.qmul.ac.uk/xmlui/handle/123456789/24789
Storr HL, Prasad R, Temple IK, Metherell LA, Savage MO, Walker JM(2015). Heterogeneity of the growth phenotype and birth size in acid-labile subunit (ALS) deficiency. J Endocrinol Invest vol. 38, (4) 407-412.
10.1007/s40618-014-0195-1
Bang P, Polak M, Woelfle J, Houchard A(2015). Effectiveness and Safety of rhIGF-1 Therapy in Children: The European Increlex� Growth Forum Database Experience. Hormone Research in Paediatrics vol. 83, (5) 345-357.
10.1159/000371798
https://qmro.qmul.ac.uk/xmlui/handle/123456789/22343
Storr HL, Dunkel L, Kowalczyk J, Savage MO, Metherell LA(2015). Genetic characterisation of a cohort of children clinically labelled as GH or IGF1 insensitive: Diagnostic value of serum IGF1 and height at presentation. European Journal of Endocrinology vol. 172, (2) 151-161.
10.1530/EJE-14-0541
Storr HL, Savage MO(2015). Management of endocrine disease: Paediatric Cushing's disease. European Journal of Endocrinology vol. 173, (1) R35-R45.
10.1530/EJE-15-0013
https://qmro.qmul.ac.uk/xmlui/handle/123456789/24883
Savage MO, Storr HL(2014). Fundamental principles of clinical and biochemical evaluation underlie the diagnosis and therapy of Cushing's syndrome. Journal of Pediatric Endocrinology and Metabolism vol. 27, (11-12) 1029-1031.
10.1515/jpem-2014-0400
Prasad R, Chan LF, Hughes CR, Kaski JP, Kowalczyk JC, Savage MO, Peters CJ, Nathwani N et al.(2014). Thioredoxin Reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD). J Clin Endocrinol Metab vol. 99, (8) E1556-E1563.
10.1210/jc.2013-3844
Prasad R, Kowalczyk JC, Meimaridou E, Storr HL, Metherell LA(2014). Oxidative stress and adrenocortical insufficiency. J Endocrinol vol. 221, (3) R63-R73.
10.1530/JOE-13-0346
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18036
Storr HL, Drake WM, Evanson J, Matson M, Berney DM, Grossman AB, Akker SA, Monson JP et al.(2014). Endonasal endoscopic transsphenoidal pituitary surgery: Early experience and outcome in paediatric Cushing's disease. Clinical Endocrinology vol. 80, (2) 270-276.
10.1111/cen.12275
Storr HL, Drake WM, Evanson J, Matson M, Berney DM, Grossman AB, Akker SA, Monson JP et al.(2014). Endonasal endoscopic transsphenoidal pituitary surgery: early experience and outcome in paediatric Cushing's disease. Clin Endocrinol (Oxf) vol. 80, (2) 270-276.
10.1111/cen.12275
Perchard R, Say J, Pitts J, Storr HL, Amin R(2014). Use of continuous glucose monitoring to identify glucose dysregulation in growth hormone insensitivity syndrome. Hormone Research in Paediatrics vol. 82, (6) 394-398.
10.1159/000369096
Prasad R, Metherell LA, Clark AJ, Storr HL(2013). Deficiency of ALADIN impairs redox homeostasis in human adrenal cells and inhibits steroidogenesis. Endocrinology vol. 154, (9) 3209-3218.
10.1210/en.2013-1241
Meimaridou E, Prasad R, Kowalczyk JC, Clark AJL, Storr HL, Metherell LA(2013). Genome sequencing reveals mitochondrial thiol systems are essential for antioxidant defence in human adrenal glands. FREE RADICAL BIOLOGY AND MEDICINE vol. 65, S38-S38.
10.1016/j.freeradbiomed.2013.08.052
Alexandraki KI, Kaltsas GA, Isidori AM, Storr HL, Afshar F, Sabin I, Akker SA, Chew SL et al.(2013). Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study. Eur J Endocrinol vol. 168, (4) 639-648.
10.1530/EJE-12-0921
Clayton P, Bonnemaire M, Dutailly P, Maisonobe P, Naudin L, Pham E, Zhang Z, Grupe A et al.(2013). Characterizing short stature by insulin-like growth factor axis status and genetic associations: Results from the prospective, cross-sectional, epidemiogenetic EPIGROW study. Journal of Clinical Endocrinology and Metabolism vol. 98, (6)
10.1210/jc.2012-4283
Williams F, Hunter S, Bradley L, Chahal HS, STORR HL, Akker SA, Kumar AV, Orme SM et al.(2013). Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation. Journal of Clinical Endocrinology and Metabolism vol. 99, (4) 1122-1131.
10.1210/jc.2013-2868
Guaraldi F, STORR HL, Ghizzoni L, Ghigo E, Savage MO(2013). Paediatric pituitary adenomas: a decade of change. Hormone Research in Paediatrics: from developmental endocrinology to clinical research vol. 81, (3) 145-155.
10.1159/000357673
Savage MO, Storr HL(2012). Pediatric Cushing's disease: Management Issues. Indian J Endocrinol Metab vol. 16, (Suppl 2) S171-S175.
10.4103/2230-8210.104032
Prasad R, Clark AJ, Storr HL(2012). Deficiency of ALADIN, the AAAS gene product, renders human adrenal and neuronal cells susceptible to oxidative stress. FREE RADICAL BIOLOGY AND MEDICINE vol. 53, S224-S224.
10.1016/j.freeradbiomed.2012.08.470
Korbonits M, Storr H, Kumar AV(2012). Familial pituitary adenomas - who should be tested for AIP mutations?. Clin Endocrinol (Oxf) vol. 77, (3) 351-356.
10.1111/j.1365-2265.2012.04445.x
Clark AJL, Storr HL, Meimaridou E, Metherell AL (2012). Oxidative Stress as a Disease Mechanism in Inherited Adrenal Failure. JOURNAL OF PATHOLOGY. vol. 226,
Clark AJL, STORR HL, Meimaridou E, Metherell LA(2012). Oxidative Stress as a Disease Mechanism in Inherited Adrenal Failure. Journal of Pathology vol. 226,
Hughes CR, STORR HL, Grossman AB, Savage MO(2011). Diagnosis and treatment of paediatric Cushing’s disease. Cushing's Disease, Editors: Swearingen, B, Biller, BMK, Springer
Metherell LA, STORR HL, Savage MO(2011). Genetic defects of the human somatotrophic axis. Oxford Textbook of Endocrinology and Diabetes, Editors: Wass, JAH, Stewart, PM, Oxford University Press
Storr HL, Alexandraki KI, Martin L, Isidori AM, Kaltsas GA, Monson JP, Besser GM, Matson M et al.(2011). Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing's disease. Eur J Endocrinol vol. 164, (5) 667-674.
10.1530/EJE-10-1120
Prasad R, Johnston LB, Savage MO, Martin L, Perry LA, Storr HL(2011). Pediatric endocrine screening for von Hippel-Lindau disease: benefits and the challenge of compliance. J Endocrinol Invest vol. 34, (4) 296-299.
10.3275/7137
Prasad R, Johnston LB, Savage MO, Martin L, Perry LA, Storr HL(2011). Pediatric endocrine screening for von Hippel-Lindau disease: benefits and the challenge of compliance. J Endocrinol Invest vol. 34, (4) 296-299.
Savage MO, Afshar F, Plowman PN, Dias RP, Grossman AB, STORR HL(2011). Special aspects of Cushing's syndrome: Childhood. Cushing's Syndrome: Pathophysiology, Diagnosis and Treatment, Editors: Bronstein, MD, Bronstein, M, Humana Press (London),
Chan LF, Vaidya M, Westphal B, Allgrove J, Martin L, Afshar F, Hindmarsh PC, Savage MO et al.(2011). Use of intravenous etomidate to control acute psychosis induced by the hypercortisolaemia in severe paediatric Cushing's disease. Horm Res Paediatr vol. 75, (6) 441-446.
10.1159/000324419
Chan LF, Hughes CR, Allgrove JA, Martin L, Afshar F, Hindmarsh PC, Savage MO, Grossman AB et al. (2010). Use of Intravenous Etomidate in a Child To Control Acute Psychosis Induced by the Hypercortisolemia Secondary to Severe Cushing's Disease. ENDOCRINE REVIEWS. vol. 31,
Dias RP, Kumaran A, Chan LF, Martin L, Afshar F, Matson M, Plowman PN, Monson JP et al.(2010). Diagnosis, management and therapeutic outcome in prepubertal Cushing's disease. Eur J Endocrinol vol. 162, (3) 603-609.
10.1530/EJE-09-0509
Savage MO, Dias RP, Chan LF, Afshar F, Plowman PN, Matson M, Grossman AB, STORR HL(2010). Diagnosis and Treatment of Cushing’s Disease in Children. Pediatric Neuroendocrinology, Editors: Loche, S, Cappa, M, Ghizzoni, L, Maghnie, M et al., Karger Publishers
Savage MO, Dias RP, Chan LF, Afshar F, Plowman NP, Matson M, Grossman AB, Storr HL(2010). Diagnosis and treatment of Cushing's disease in children. Endocr Dev vol. 17, 134-145.
10.1159/000262535
Storr HL, Metherell LA, Dias R, Savage MO, Rasmussen AK, Clark AJL, Main KM(2010). Familial Isolated Primary Pigmented Nodular Adrenocortical Disease Associated with a Novel Low Penetrance PRKAR1A Gene Splice Site Mutation. HORM RES PAEDIAT vol. 73, (2) 115-119.
10.1159/000277629
Storr HL, Metherell LA, Dias R, Savage MO, Rasmussen AK, Clark AJL, Main KM(2010). Familial isolated primary pigmented nodular adrenocortical disease associated with a novel low penetrance PRKAR1A gene splice site mutation. Horm Res Paediatr vol. 73, (2) 115-119.
10.1159/000277629
Storr HL, Kind B, Parfitt DA, Chapple JP, Lorenz M, Koehler K, Huebner A, Clark AJL(2009). Deficiency of ferritin heavy-chain nuclear import in triple a syndrome implies nuclear oxidative damage as the primary disease mechanism. Mol Endocrinol vol. 23, (12) 2086-2094.
10.1210/me.2009-0056
Savage MO, Storr HL(2009). Growth and body composition at diagnosis and postcure in children with Cushing's syndrome. Pediatric Health vol. 3, (1) 13-18.
10.2217/17455111.3.1.13
Dias RP, Kumaran A, Chan LF, Martin L, Afshar F, Matson M, Plowman PN, Monson JP et al.(2009). Prepubertal Cushing's disease: diagnosis, management and therapeutic outcome. HORM RES vol. 72, 72-72.
Savage MO, Chan LF, Grossman AB, Storr HL(2008). Work-up and management of paediatric Cushing's syndrome. Curr Opin Endocrinol Diabetes Obes vol. 15, (4) 346-351.
10.1097/MED.0b013e328305082f
Cooray SN, Chan L, Metherell L, STORR HL, Clark AJ(2008). Adrenocorticotropin resistance syndromes. Endocrine developmentD vol. 13, 99-116.
Savage MO, Chan LF, Afshar F, Plowman PN, Grossman AB, Storr HL(2008). Advances in the management of paediatric Cushing's disease. HORM RES vol. 69, (6) 327-333.
10.1159/000117388
Storr H, Alexandraki K, Chan L, Martin L, Monson J, Besser M, Grossman A, Savage M(2008). Comparisons in the epidemiology and diagnostic features between paediatric and adult Cushing's disease. HORM RES vol. 70, 24-25.
Dias R, Chaplin T, Jones J, Hall C, Ston H, Patton M, Savage M, Clark A(2008). Homozygosity mapping of possible genetic locus in small for gestational age siblings with a previously undescribed severe short stature syndrome. HORM RES vol. 70, 110-110.
Doufexis M, Storr HL, King PJ, Clark AJL(2007). Interaction of the melanocortin 2 receptor with nucleoporin 50: evidence for a novel pathway between a G-protein-coupled receptor and the nucleus. FASEB J vol. 21, (14) 4095-4100.
10.1096/fj.06-7927com
Chan LF, Storr HL, Grossman AB, Savage MO(2007). Pediatric Cushing's syndrome: Clinical features, diagnosis, and treatment. ARQ BRAS ENDOCRINOL vol. 51, (8) 1261-1271.
10.1590/s0004-27302007000800012
Savage MO, STORR HL(2007). Linear Growth in Adrenal Disease. Growth Disorders 2E, Editors: Kelnar, C, Savage, M, Saenger, P, Cowell, C et al., CRC Press
Dupuis CC, Storr HL, Perry LA, Ho JTF, Ahmed L, Ong KK, Dunger DB, Monson JP et al.(2007). Abnormal puberty in paediatric Cushing's disease: relationship with adrenal androgen, sex hormone binding globulin and gonadotrophin concentrations. CLIN ENDOCRINOL vol. 66, (6) 838-843.
10.1111/j.1365-2265.2007.02822.x
Storr HL, Chan LF, Grossman AB, Savage MO(2007). Paediatric Cushing's syndrome: epidemiology, investigation and therapeutic advances. TRENDS ENDOCRIN MET vol. 18, (4) 167-174.
10.1016/j.tem.2007.03.006
Chan LF, Storr HL, Plowman PN, Perry LA, Besser GM, Grossman AB, Savage MO(2007). Long-term anterior pituitary function in patients with paediatric Cushing's disease treated with pituitary radiotherapy. EUR J ENDOCRINOL vol. 156, (4) 477-482.
10.1530/EJE-06-0588
Storr HL, Savage MO(2007). Adrenal disorders. Growth Disorders, Second Edition,
Savage MO, Storr HL, Chan LF, Grossman AB(2007). Diagnosis and treatment of pediatric Cushing's disease. Pituitary vol. 10, (4) 365-371.
10.1007/s11102-007-0056-4
Peters CJ, Ahmed ML, Storr HL, Davies KM, Martin LJ, Allgrove J, Grossman AB, Savage MO(2007). Factors influencing skeletal maturation at diagnosis of paediatric Cushing's disease. HORM RES vol. 68, (5) 231-235.
10.1159/000101336
Greening JE, Storr HL, McKenzie SA, Davies KM, Martin L, Grossman AB, Savage MO(2006). Linear growth and body mass index in pediatric patients with Cushing's disease or simple obesity. J ENDOCRINOL INVEST vol. 29, (10) 885-887.
10.1007/BF03349191
Peters CJ, Storr HL, Grossman AB, Savage MO(2006). The role of corticotrophin-releasing hormone in the diagnosis of Cushing's syndrome. EUROPEAN JOURNAL OF ENDOCRINOLOGY vol. 155, S93-S98.
10.1530/eje.1.02238
Camacho-Hübner C, Rose S, Preece MA, Sleevi M, Storr HL, Miraki-Moud F, Minuto F, Frystyk J et al.(2006). Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome. J Clin Endocrinol Metab vol. 91, (4) 1246-1253.
10.1210/jc.2005-1017
Storr H, Koehler K, Huebner A, Chapple JP, Clark AJL(2006). A candidate interacting protein for the nuclear pore protein ALADIN: a potential pathogenic mechanism for the triple A syndrome. HORM RES vol. 65, 16-16.
Chan L, Storr H, Plowman PN, Perry L, Monson J, Besser GM, Grossman A, Savage M(2006). Anterior pituitary function in the long-term follow-up of five paediatric Cushing's disease patients treated with pituitary radiotherapy. HORM RES vol. 65, 186-186.
Peters CJ, Ahmed ML, Storr HL, Davies K, Martin L, Grossman AB, Allgrove J, Savage MO(2006). Factors influencing skeletal maturation at diagnosis of paediatric Cushing's disease. HORM RES vol. 65, 117-118.
Grossman AB, SAVAGE MO, Storr HL, Dias R, Isidori AM, Perry LA(2006). The Discriminatory Value of the Low Dose Dexamethasone Suppression Test in Paediatric Cushing’s Syndrome. Hormone Research vol. 65, 159-162.
10.1159/000091830
Dias R, Storr HL, Perry LA, Isidori AM, Grossman AB, Savage MO(2006). The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndrome. HORM RES vol. 65, (3) 159-162.
10.1159/000091830
CLARK AJL, Storr HL, Priestley JV, Michael GJ(2005). Identification of the sites of expression of triple a syndrome mRNA in the rat using hybridisation. Neuroscience vol. 131, (1) 113-123.
10.1016/j.neuroscience.2004.10.029
Joshi SM, Hewitt RJD, Storr HL, Rezajooi K, Ellamushi H, Grossman AB, Savage MO, Afshar F(2005). Cushing's disease in children and adolescents: 20 years of experience in a single neurosurgical center. NEUROSURGERY vol. 57, (2) 281-285.
10.1227/01.NEU.0000166580.94215.53
Storr HL, Afshar F, Matson M, Sabin I, Davies KM, Evanson J, Plowman PN, Besser GM et al.(2005). Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease. EUR J ENDOCRINOL vol. 152, (6) 825-833.
10.1530/eje.1.01921
Davies JH, Storr HL, Davies K, Monson JP, Besser GM, Afshar F, Plowman PN, Grossman AB et al.(2005). Final adult height and body mass index after cure of paediatric Cushing's disease. CLIN ENDOCRINOL vol. 62, (4) 466-472.
10.1111/j.1365-2265.2005.02244.x
Scommegna S, Greening JP, Storr HL, Davies KM, Shaw NJ, Monson JP, Grossman AB, Savage MO(2005). Bone mineral density at diagnosis and following successful treatment of pediatric Cushing's disease. J ENDOCRINOL INVEST vol. 28, (3) 231-235.
10.1007/bf03345378
Storr HL, Clark AJL, Priestley JV, Michael GJ(2005). Identification of the sites of expression of triple a syndrome mRNA in the rat using in situ hybridisation. NEUROSCIENCE vol. 131, (1) 113-123.
10.1016/j.neuroscience.2004.10.029
Storr HL, Mitchell H, Swords FM, Main KM, Hindmarsh PC, Betts PR, Shaw NJ, Johnston DI et al.(2004). Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia. CLIN ENDOCRINOL vol. 61, (5) 553-559.
10.1111/j.1365-2265.2004.02124.x
Storr HL, Isidori AM, Monson JP, Besser GM, Grossman AB, Savage MO(2004). Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis. J CLIN ENDOCR METAB vol. 89, (8) 3818-3820.
10.1210/jc.2003-031531
Chan LF, Storr HL, Scheimberg I, Perry LA, Banerjee K, Miraki-Moud F, Camacho-Hubner C, Savage MO(2004). Pseudo-precocious puberty caused by a juvenile granulosa cell tumor secreting androstenedione, inhibin and insulin-like growth factor-I. J PEDIATR ENDOCR MET vol. 17, (4) 679-684.
10.1515/jpem.2004.17.4.679
Savage MO, Storr HL, Grossman AB, Krassas GE(2003). Growth and growth hormone secretion in paediatric Cushing's disease. Hormones (Athens) vol. 2, (2) 93-97.
10.14310/horm.2002.1187
Storr HL, Plowman PN, Carroll PV, François I, Krassas GE, Afshar F, Besser GM, Grossman AB et al.(2003). Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment. J Clin Endocrinol Metab vol. 88, (1) 34-37.
10.1210/jc.2002-021032
Storr HL, Barwick TD, Snodgrass GAI, Booy R, Morel Y, Reznek RH, Savage MO(2003). Hyperplasia of adrenal rest tissue causing a retroperitoneal mass in a child with 11 beta-hydroxylase deficiency. HORM RES vol. 60, (2) 99-102.
10.1159/000071878
Storr HL, Savage MO, Clark AJL(2002). Advances in the understanding of the genetic basis of adrenal insufficiency. J Pediatr Endocrinol Metab vol. 15 Suppl 5, 1323-1328.
Holness MJ, STORR HL(1993). Altered interactions between lipogenesis and glycogenesis in liver during fructose feeding. Biochemical Society Transactions vol. 21, Article 2,
Return to top